254 related articles for article (PubMed ID: 12811365)
1. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.
Nishizato Y; Ieiri I; Suzuki H; Kimura M; Kawabata K; Hirota T; Takane H; Irie S; Kusuhara H; Urasaki Y; Urae A; Higuchi S; Otsubo K; Sugiyama Y
Clin Pharmacol Ther; 2003 Jun; 73(6):554-65. PubMed ID: 12811365
[TBL] [Abstract][Full Text] [Related]
2. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1).
Niemi M; Schaeffeler E; Lang T; Fromm MF; Neuvonen M; Kyrklund C; Backman JT; Kerb R; Schwab M; Neuvonen PJ; Eichelbaum M; Kivistö KT
Pharmacogenetics; 2004 Jul; 14(7):429-40. PubMed ID: 15226675
[TBL] [Abstract][Full Text] [Related]
3. Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics.
Mwinyi J; Johne A; Bauer S; Roots I; Gerloff T
Clin Pharmacol Ther; 2004 May; 75(5):415-21. PubMed ID: 15116054
[TBL] [Abstract][Full Text] [Related]
4. Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril.
Maeda K; Ieiri I; Yasuda K; Fujino A; Fujiwara H; Otsubo K; Hirano M; Watanabe T; Kitamura Y; Kusuhara H; Sugiyama Y
Clin Pharmacol Ther; 2006 May; 79(5):427-39. PubMed ID: 16678545
[TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction between genetics and disease on pravastatin disposition.
Clarke JD; Hardwick RN; Lake AD; Lickteig AJ; Goedken MJ; Klaassen CD; Cherrington NJ
J Hepatol; 2014 Jul; 61(1):139-47. PubMed ID: 24613363
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis.
Nozawa T; Nakajima M; Tamai I; Noda K; Nezu J; Sai Y; Tsuji A; Yokoi T
J Pharmacol Exp Ther; 2002 Aug; 302(2):804-13. PubMed ID: 12130747
[TBL] [Abstract][Full Text] [Related]
7. Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.
Kivistö KT; Niemi M
Pharm Res; 2007 Feb; 24(2):239-47. PubMed ID: 17177112
[TBL] [Abstract][Full Text] [Related]
8. Explaining Ethnic Variability of Transporter Substrate Pharmacokinetics in Healthy Asian and Caucasian Subjects with Allele Frequencies of OATP1B1 and BCRP: A Mechanistic Modeling Analysis.
Li R; Barton HA
Clin Pharmacokinet; 2018 Apr; 57(4):491-503. PubMed ID: 28653144
[TBL] [Abstract][Full Text] [Related]
9. Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers.
Chung JY; Cho JY; Yu KS; Kim JR; Oh DS; Jung HR; Lim KS; Moon KH; Shin SG; Jang IJ
Clin Pharmacol Ther; 2005 Oct; 78(4):342-50. PubMed ID: 16198653
[TBL] [Abstract][Full Text] [Related]
10. Mixed effects of OATP1B1, BCRP and NTCP polymorphisms on the population pharmacokinetics of pravastatin in healthy volunteers.
Lu XF; Zhou Y; Bi KS; Chen XH
Xenobiotica; 2016 Sep; 46(9):841-9. PubMed ID: 26744986
[TBL] [Abstract][Full Text] [Related]
11. Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8).
Yee SW; Nguyen AN; Brown C; Savic RM; Zhang Y; Castro RA; Cropp CD; Choi JH; Singh D; Tahara H; Stocker SL; Huang Y; Brett CM; Giacomini KM
J Pharm Sci; 2013 Sep; 102(9):3451-7. PubMed ID: 23649425
[TBL] [Abstract][Full Text] [Related]
12. Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin.
Igel M; Arnold KA; Niemi M; Hofmann U; Schwab M; Lütjohann D; von Bergmann K; Eichelbaum M; Kivistö KT
Clin Pharmacol Ther; 2006 May; 79(5):419-26. PubMed ID: 16678544
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans.
Tirona RG; Leake BF; Merino G; Kim RB
J Biol Chem; 2001 Sep; 276(38):35669-75. PubMed ID: 11477075
[TBL] [Abstract][Full Text] [Related]
14. Influence of SLCO1B1 polymorphisms on the drug-drug interaction between darunavir/ritonavir and pravastatin.
Aquilante CL; Kiser JJ; Anderson PL; Christians U; Kosmiski LA; Daily EB; Hoffman KL; Hopley CW; Predhomme JA; Schniedewind B; Sidhom MS
J Clin Pharmacol; 2012 Nov; 52(11):1725-38. PubMed ID: 22174437
[TBL] [Abstract][Full Text] [Related]
15. Utility of Oatp1a/1b-knockout and OATP1B1/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein.
Higgins JW; Bao JQ; Ke AB; Manro JR; Fallon JK; Smith PC; Zamek-Gliszczynski MJ
Drug Metab Dispos; 2014 Jan; 42(1):182-92. PubMed ID: 24194513
[TBL] [Abstract][Full Text] [Related]
16. Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants.
Ho RH; Choi L; Lee W; Mayo G; Schwarz UI; Tirona RG; Bailey DG; Stein CM; Kim RB
Pharmacogenet Genomics; 2007 Aug; 17(8):647-56. PubMed ID: 17622941
[TBL] [Abstract][Full Text] [Related]
17. Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug-Drug Interaction and Associated Biomarker Levels in Healthy Volunteers.
Yee SW; Giacomini MM; Shen H; Humphreys WG; Horng H; Brian W; Lai Y; Kroetz DL; Giacomini KM
Clin Transl Sci; 2019 Jul; 12(4):388-399. PubMed ID: 30982223
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the organic anion-transporting polypeptide 1B1 by quercetin: an in vitro and in vivo assessment.
Wu LX; Guo CX; Chen WQ; Yu J; Qu Q; Chen Y; Tan ZR; Wang G; Fan L; Li Q; Zhang W; Zhou HH
Br J Clin Pharmacol; 2012 May; 73(5):750-7. PubMed ID: 22114872
[TBL] [Abstract][Full Text] [Related]
19. SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin.
Niemi M; Pasanen MK; Neuvonen PJ
Clin Pharmacol Ther; 2006 Oct; 80(4):356-66. PubMed ID: 17015053
[TBL] [Abstract][Full Text] [Related]
20. [OATP 1B1 T521C/A388G is an important polymorphism gene related to neonatal hyperbilirubinemia].
Zhang HX; Zhao X; Yang Z; Peng CY; Long R; Li GN; Li J; He ZK
Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):650-5. PubMed ID: 21092521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
